Status
Conditions
Treatments
About
The aim of the study is to evaluate osseous regenerative efficacy of eggshell derived nanohydroxyapatite in comparison with hydroxyapatite The test group includes patients with intrabony defects where flap surgery will be performed & Eggshell derived nano hydroxyapatite (ESnHA) is placed.
Full description
Experimental : Main treatment group Eggshell derived nano hydroxyapatite is placed into defect site Comparator : In patients allocated to control group, only Hydroxyapatite is placed.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Presence of Two-walled or three-walled intrabony defects & Probing pocket depths (PPD) of >5mm after initial therapy Systemically healthy male and female patients of age >18 years
Exclusion criteria
Medically compromised patients Pregnant women, Heavy smokers, and Patients who underwent radiotherapy or chemotherapy
Primary purpose
Allocation
Interventional model
Masking
28 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal